Abstract: One example embodiment is a lignanamide that includes a benzo-angular triquinane skeleton. The lignanamide is represented by formula (I) and any derivative of the formula (I), in which R is represented by —OH or —OCH3. Another example embodiment relates to a method of treating neurodegenerative disease by administering the lignanamide of the formula (I) to a person in need thereof.

Abstract: A mesh WLAN controller (100) operates in mesh soft-access-point or mesh client modes. When operating in the mesh client mode it performs a mesh network scan, for detecting at least one mesh WLAN BSS (202), send mesh client access requests to mesh WLAN BSSs detected, and, if mesh client access is achieved, provide information indicative to the accessed WLAN BSSs of any other mesh WLAN BSS to which mesh client access is achieved, and if mesh client access is not achieved with any of the detected mesh WLAN BSSs, operate in the mesh soft-access-point mode. Upon receiving an instruction to operate in a mesh bridge-client mode, the controller detects messages from any of the mesh WLAN BSSs (204, 206) with mesh client access, and forwards the received mesh WLAN messages within any other of the mesh WLAN BSSs to which mesh client access has been achieved.

Abstract: The invention relates to a method for transmitting information, particularly network parameters for connecting to a wireless network, from a provisioning device to a wireless device via a wireless interface. The information is obtained in an encoded form in the provisioning device and the provisioning device transmits a sequence of data packets (21) in accordance with a pattern generated based on the encoded information. Each element of the pattern correspond to a predetermined time distance between consecutive data packets (21) or to a predetermined data packet length, and the data packets (21) have a length which is smaller than a maximum length supported by the wireless interface.

Abstract: A method for generating an accelerator program is disclosed, to help increase utilization of an accelerator and increase program development efficiency. In some feasible implementations of the present invention, the method includes: obtaining an accelerator program description that is based on a state machine, where the accelerator program description includes multiple state machines separately configured to implement an application program, and the multiple state machines form a pipeline according to a data dependency in a directed acyclic graph DAG corresponding to the application program; and performing state machine splicing on the state machines in the accelerator program description by using an accelerator compilation tool, to generate an accelerator program.

Abstract: An image processing device and a method performed by the device are provided. The image processing device includes processors forming a partitioning unit, processors forming a partitioning unit, and memories shared by the partitioning unit and the classification unit. The partitioning unit obtains an image from a first memory, partitions the image into one or more areas, each area includes one or more objects to be classified, and saves information of the partitioning of the image in a second memory. The classification unit obtains the image from the first memory, obtains information of partitioning of the image from the second memory and classifies the objects in each area of the image to obtain a classification result of the image. The image processing device may further include a scheduling unit for controlling optimizing performance of the partitioning unit and the classification unit.

Abstract: A method and a device for interworking between access technology networks are disclosed. The method includes: a decision-making entity for interworking between a first access technology network and a second access technology network judging whether it is required to adopt a terminal power saving priority principle, and when determining to adopt the terminal power saving priority principle, triggering an interworking process between the first access technology network and the second access technology network only when a preset triggering event occurs.

Abstract: Provided are a method and device for processing measurement configuration. The method includes: after a HO flow or a reselection flow is triggered in a source cell, UE processes a WLAN interworking mechanism measurement configuration in at least one of manners as follows: the UE continues using a current WLAN interworking mechanism measurement configuration; the UE modifies a target frequency point in the current WLAN interworking mechanism measurement configuration into the whole frequency band for measurement; the UE requests for a WLAN interworking mechanism measurement configuration corresponding to a target cell; and the UE suspends WLAN interworking mechanism measurement until the UE receives the WLAN interworking mechanism measurement configuration corresponding to the target cell.

Abstract: The present disclosure provide a video communication method and system, applied to a scenario of video communication between a first location and a second location, and at least two users at the second location participate in the video communication. The method includes: determining a first user and a second user that are in a call or that are going to have a call with each other; obtaining an eye-to-eye virtual view image of the first user; and displaying the eye-to-eye virtual view image of the first user on a display at the second location in a manner used for corresponding to the second user, so that the eye-to-eye virtual view image of the first user corresponds to the second user.

Abstract: A refrigerator (100) includes a liner (10) forming a refrigeration compartment (101); a wine rack (20) having a bottle placing portion (21) and an end being connected to a side wall of the refrigeration compartment (101) and pivoting about an axis in an up-down direction, in which the wine rack is capable of shifting between a first position where the wine rack abuts against to the side wall and a second position where the wine rack is perpendicular to the side wall; and an auxiliary bracket (30) being connected to a rear side wall of the refrigeration compartment (101) and opposite to the bottle placing portion (21). The wine rack of the refrigerator occupies a small space in a refrigeration compartment when not in use.

Abstract: The administration of a compound advantageously efficacious as ROS1 inhibitor and its effect on subjects with cancer includes administering a compound having certain structural components such as a quinoline moiety in the backbone and at least one tertiary amine containing moiety in a side chain as well as heteroatoms, in particular oxygen atoms, present in the backbone and the side chain for treating a subject suffering from a disease such as cancer. The presence of such structural components allows for an advantageous interaction with the ROS1 kinase domain, in particular with the hinge region. The administered compounds represent a highly promising opportunity in particular for patients bearing ROS1-dependent cancer. A method for targeting tumor cells harboring an abnormality in ROS1 gene includes contacting a cell with compounds of the present invention as well as pharmaceutical compositions comprising such compounds.

Abstract: Methods, computer program products, and network authority devices are presented. The methods include, for instance: updating a source network with migration information of a virtual machine to redirect network traffic for the virtual machine to a destination network; and updating at least one remote network with the migration information of the virtual machine. In one embodiment, the updating includes updating the source network concurrent with a migration of the virtual machine to minimize interruption of the network traffic. In another embodiment, the updating includes updating a network device of the source network to forward the network traffic for the virtual machine to another network device of the destination network. In a further embodiment, the updating includes updating the source network to redirect the network traffic from at least one client on the at least one remote network.

Abstract: The present invention discloses a method for processing non-unicast routes information in a TRILL network and a corresponding RBridge, wherein the RBridge has a neighbor relation with a plurality of other RBridges in the TRILL network, and the RBridge is the RBridge which computes non-unicast routes information in the neighbor relation, and in the method, the RBridge executes steps of: sending an acknowledgement message to the plurality of other RBridges, wherein the acknowledgement message acknowledges that the RBridge is the RBridge which computes the non-unicast routes information; obtaining a network topology related to the non-unicast routes information in the TRILL network; computing the non-unicast routes information based on the network topology; and distributing the computed non-unicast routes information to the plurality of other RBridges. The method and the corresponding RBridge are capable of reducing consumption of CPU resource of RBridges in the TRILL network.

Abstract: Methods, computer program products, and network authority devices are presented. The methods include, for instance: updating a source network with migration information of a virtual machine to redirect network traffic for the virtual machine to a destination network; and updating at least one remote network with the migration information of the virtual machine. In one embodiment, the updating includes updating the source network concurrent with a migration of the virtual machine to minimize interruption of the network traffic. In another embodiment, the updating includes updating a network device of the source network to forward the network traffic for the virtual machine to another network device of the destination network. In a further embodiment, the updating includes updating the source network to redirect the network traffic from at least one client on the at least one remote network.

Abstract: A compound for treating a disease, in particular cancer like non-small cell lung cancer, exceptionally inhibits activity of oncogenic ALK kinase. Compositions, particularly pharmaceutical compositions, are provided comprising this compound. Methods for targeting cancer cells harboring an abnormality in the ALK gene are also The compound for treating a disease has certain structural elements, namely a tricyclic, more specifically heterocyclic, backbone as the core part of the compound at least one highly electronegative atom in form of a tertiary amine attached to the backbone via an at most 6-membered linking group with a terminal highly electronegative atom in form of a nitrogen as secondary amine, and a further hydrophobic moiety fused to the backbone. The structural components allow for an advantageous interaction with the ALK kinase domain. The compound therefor represents a highly promising treatment option for patients in particular those bearing ALK-dependent non-small cell lung cancer.

Abstract: One embodiment relates to a method of treating lung cancer by administering a compound of formula I to a patient.

Abstract: One example embodiment relates to a method of treating non-small cell lung cancer by administering a compound of formula (I) to a patient.

Abstract: The present invention provides methods for treatment of a RAS-positive disease, in particular KRAS-positive non-small cell lung cancer as well as a method for potentiating the apoptotic activity of a PDE? inhibitor by combining the PDE? inhibitor with a direct autophagy inhibitor. The PDE? inhibitor is preferably, but not exclusively, deltarasin, and the direct autophagy inhibitor is in particular 3-methyladenine. Further provided by the present invention are a kit and a pharmaceutical composition comprising the PDE? inhibitor and a direct autophagy inhibitor. The methods of the present invention in particular provide a new treatment option for RAS-positive diseases such as KRAS-positive non-small cell lung cancer allowing for an increased apoptotic activity of the PDE? inhibitor by simultaneously blocking its “tumor protective” autophagy.

Abstract: A location system provides a location service for determining a location of a mobile device. A node of the location system comprises: a signal processing module, and a wireless interface which communicates wirelessly according to a standardized wireless networking protocol. The protocol defines a request message for sending a request from the mobile device to the node, the request message having a network ID field for specifying a network to which the request is directed. The wireless interface receives, from the mobile device, an instance of the request message including an ID of the location service, this being carried in the network ID field. The signal processing module detects the ID of the location service in this field, and in response captures a measurement of the received instance of the request, for use in determining the location of the mobile device in conjunction with measurements from other nodes.

Abstract: For logical multicasting in overlay networks, at a data processing system, an original unicast packet is received from a first component in a first computing node in an overlay network. To cause multicasting in the overlay network the received original unicast packet was unicast by the first computing node only to the data processing system, and a multicast data structure for the overlay network is maintained only by the data processing system, the multicast data structure containing information of each receiver that is configured to receive unicast packets during logical multicasting in the overlay network. From a set of subscriber receivers in the multicast data structure, a subset of the subscriber receivers is selected. A copy of the original unicast packet is unicast to each subscriber receiver in the subset.

Abstract: One example embodiment relates to a method of treating lung cancer by administering a compound of formula I to a subject in need thereof. Another embodiment relates to a method to treat Non-Small Cell Lung Cancer (NSCLC) by administering the compound of formula I to a patient.